Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Mar 28;40(2):414-422.
doi: 10.1093/fampra/cmac084.

Implementing a home-based virtual hypertension programme-a pilot feasibility study

Affiliations
Randomized Controlled Trial

Implementing a home-based virtual hypertension programme-a pilot feasibility study

Aditi Gupta et al. Fam Pract. .

Abstract

Introduction: Implementing a health system-based hypertension programme may lower blood pressure (BP).

Methods: We performed a randomized, controlled pilot study to assess feasibility, acceptability, and safety of a home-based virtual hypertension programme integrating evidence-based strategies to overcome current barriers to BP control. Trained clinical pharmacists staffed the virtual collaborative care clinic (vCCC) to remotely manage hypertension using a BP dashboard and phone "visits" to monitor BP, adherence, side effects of medications, and prescribe anti-hypertensives. Patients with uncontrolled hypertension were identified via electronic health records. Enrolled patients were randomized to either vCCC or usual care for 3 months. We assessed patients' home BP monitoring behaviour, and patients', physicians', and pharmacists' perspectives on feasibility and acceptability of individual programme components.

Results: Thirty-one patients (vCCC = 17, usual care = 14) from six physician clinics completed the pilot study. After 3 months, average BP decreased in the vCCC arm (P = 0.01), but not in the control arm (P = 0.45). The vCCC participants measured BP more (9.9 vs. 1.2 per week, P < 0.001). There were no intervention-related adverse events. Participating physicians (n = 6), pharmacists (n = 5), and patients (n = 31) rated all programme components with average scores of >4.0, a pre-specified benchmark. Nine adaptations in vCCC design and delivery were made based on potential barriers to implementing the programme and suggestions.

Conclusion: A home-based virtual hypertension programme using team-based care, technology, and a logical integration of evidence-based strategies is safe, acceptable, and feasible to intended users. These pilot data support studies to assess the effectiveness of this programme at a larger scale.

Keywords: geriatrics; hypertension (high blood pressure); patient adherence; patient education; primary care; self-management; telemedicine.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

Fig. 1.
Fig. 1.
Blood pressure outcomes. (A) Average blood pressure in the virtual collaborative care clinic (vCCC) and usual care with education (control) arms at baseline and at 3 months. (B) Number of home blood pressure readings by week in the vCCC and usual care with education (control) arms (n = 24)*. *N = 24 as data from initial participants was excluded from this analysis. Home BP readings from the control arm were not available during the initial part of the study. Home BP readings were later made available to monitor frequency of BP monitoring.
Fig. 2.
Fig. 2.
Patient perception of (A) acceptability and (B) feasibility of the virtual collaborative care clinic (vCCC) intervention components. (A) Patient perception of acceptability. (B) Patient perception of feasibility.
Fig. 3.
Fig. 3.
Physician and pharmacist perceptions of (A) acceptability and (B) feasibility of the virtual collaborative care clinic (vCCC) intervention components at baseline and at 3 months. (A) Physician and pharmacist perceptions of acceptability. (B) Physician and pharmacist perceptions of feasibility.

References

    1. Whelton Paul K, Carey Robert M, Aronow Wilbert S, Casey Donald E, Collins Karen J, Dennison Himmelfarb C, DePalma Sondra M, Gidding S, Jamerson Kenneth A, Jones Daniel W, et al. . 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):e13–e115. - PubMed
    1. Bress AP, Kramer H, Khatib R, Beddhu S, Cheung AK, Hess R, Bansal VK, Cao G, Yee J, Moran AE, et al. . Potential deaths averted and serious adverse events incurred from adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) intensive blood pressure regimen in the United States: projections from NHANES (National Health and Nutrition Examination Survey). Circulation. 2017;135(17):1617–1628. - PMC - PubMed
    1. Muntner P, Hardy ST, Fine LJ, Jaeger BC, Wozniak G, Levitan EB, Colantonio LD.. Trends in blood pressure control among US adults with hypertension, 1999–2000 to 2017–2018. JAMA. 2020;324(12):1190–1200. - PMC - PubMed
    1. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW.. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71(19):e127–e248. - PubMed
    1. Drawz PE, Agarwal A, Dwyer JP, Horwitz E, Lash J, Lenoir K, McWilliams A, Oparil S, Rahbari-Oskoui F, Rahman M, et al. . Concordance between blood pressure in the systolic blood pressure intervention trial and in routine clinical practice. JAMA Intern Med. 2020;180(12):1655–1663. - PMC - PubMed

Publication types

Substances